comparemela.com

Latest Breaking News On - Quatar investment authority - Page 1 : comparemela.com

Flagship Pioneering s Senda Bio secures $123M for new programmable medicines

Biotech startup Senda Biosciences is developing technology that yields a new type of medicine with two programming components: one directs the therapy to go to a particular destination in the body while the second tells the therapy what to do once it gets there. With the Series C financing, Senda aims to reach the clinic in 2024.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.